Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide (vol 26, pg 156, 2023)

被引：1
|
作者：
Pollock, Yaoyao
Smith, Matthew R.
Saad, Fred
Chowdhury, Simon
Oudard, Stephane
Hadaschik, Boris
Olmos, David
Lee, Ji Youl
Uemura, Hiroji
Bhaumik, Amitabha
Londhe, Anil
Rooney, Brendan
Brookman-May, Sabine D.
De Porre, Peter
Mundle, Suneel D.
Small, Eric J.
机构：
[1] University of California San Francisco,The Helen Diller Family Comprehensive Cancer Center
[2] Massachusetts General Hospital Cancer Center and Harvard Medical School,Georges Pompidou Hospital
[3] Centre Hospitalier de l’Université de Montréal,Spanish National Cancer Research Centre (CNIO)
[4] Université de Montréal,Department of Urology, Seoul St. Mary’s Hospital, College of Medicine
[5] Guy’s,undefined
[6] King’s and St. Thomas’ Hospitals,undefined
[7] Great Maze Pond,undefined
[8] University de Paris,undefined
[9] University of Duisburg-Essen,undefined
[10] Essen,undefined
[11] and Ruprecht-Karls-University Heidelberg,undefined
[12] Madrid and Biomedical Research Institute of Málaga (IBIMA),undefined
[13] The Catholic University of Korea,undefined
[14] Yokohama City University Medical Center,undefined
[15] Janssen Research & Development,undefined
[16] Janssen Research & Development,undefined
[17] Janssen Research & Development,undefined
[18] Ludwig-Maximilians-University,undefined
[19] Janssen Research & Development,undefined
[20] Janssen Research & Development,undefined
[21] St. Joseph Health Medical Group,undefined
[22] Providence St. Joseph Health,undefined
来源：
PROSTATE CANCER AND PROSTATIC DISEASES | 2023年 / 26卷 / 04期
关键词：
D O I：
10.1038/s41391-023-00683-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：813 / 813
页数：1
相关论文
共 50 条
  • [31] Current opportunities of therapy for patients with non-metastatic castration-resistant prostate cancer
    Alekseev, B. Ya
    Nushko, K. M.
    Kozlova, P. S.
    Kaprin, A. D.
    Mailyan, O., I
    ONKOUROLOGIYA, 2020, 16 (03): : 190 - 197
  • [32] New treatment standard for patients with non-metastatic castration-resistant prostate cancer
    Alekseev, B. Ya
    ONKOUROLOGIYA, 2018, 14 (03): : 68 - 77
  • [33] Real-world use of darolutamide, enzalutamide, and apalutamide for non-metastatic castration-resistant prostate cancer (DEAR).
    George, Daniel J.
    Khan, Nasreen
    Constantinovici, Niculae
    Khan, Javeed
    Chen, Guifang
    Xu, Julie
    Ortiz, Jorge A.
    Morgans, Alicia K.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [34] Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective study
    Hara, Shuhei
    Mori, Keiichiro
    Fukuokaya, Wataru
    Tomomasa, Naoya
    Oguchi, Takahiro
    Takahashi, Yusuke
    Saito, Shun
    Katami, Jun
    Sano, Takayuki
    Kadena, Soushi
    Hashimoto, Masaki
    Yata, Yuji
    Nishi, Eriko
    Suhara, Yushi
    Takamizawa, Shigeyoshi
    Kurawaki, Shiro
    Suzuki, Hirotaka
    Miyajima, Keiichiro
    Iwatani, Kosuke
    Urabe, Fumihiko
    Ito, Kagenori
    Yanagisawa, Takafumi
    Tsuzuki, Shunsuke
    Shimomura, Tatsuya
    Kimura, Takahiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (08) : 1191 - 1197
  • [35] Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide
    Rathkopf, D. E.
    Smith, M. R.
    Ryan, C. J.
    Berry, W. R.
    Shore, N. D.
    Liu, G.
    Higano, C. S.
    Alumkal, J. J.
    Hauke, R.
    Tutrone, R. F.
    Saleh, M.
    Maneval, E. Chow
    Thomas, S.
    Ricci, D. S.
    Yu, M. K.
    de Boer, C. J.
    Trinh, A.
    Kheoh, T.
    Bandekar, R.
    Scher, H. I.
    Antonarakis, E. S.
    ANNALS OF ONCOLOGY, 2017, 28 (09) : 2264 - 2271
  • [36] Physician preferences for non-metastatic castration-resistant prostate cancer treatment
    Srinivas, Sandy
    Mohamed, Ateesha F.
    Appukkuttan, Sreevalsa
    Botteman, Marc
    Ng, Xinyi
    Joshi, Namita
    Horodniceanu, Erica
    Waldeck, A. Reginald
    Simmons, Stacey J.
    BMC UROLOGY, 2020, 20 (01)
  • [37] Decisions and dilemmas in non-metastatic castration-resistant prostate cancer management
    Alfredo Tartarone
    Rosa Lerose
    Marina Tartarone
    Medical Oncology, 39
  • [38] Real-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients With Non-Metastatic Castration-Resistant Prostate Cancer
    Lowentritt, Benjamin
    Brown, Gordon
    Pilon, Dominic
    Ellis, Lorie
    Germain, Guillaume
    Rossi, Carmine
    Lefebvre, Patrick
    Kernen, Kenneth
    Sieber, Paul
    Shore, Neal
    UROLOGY, 2022, 166 : 182 - 188
  • [39] Correction to: Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
    Lesley J. Scott
    Targeted Oncology, 2022, 17 : 381 - 381
  • [40] The Current Landscape of Treatment in Non-Metastatic Castration-Resistant Prostate Cancer
    El-Amm, Joelle
    Aragon-Ching, Jeanny B.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2019, 13
12345